Page last updated: 2024-08-26

butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide and morphine

butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide has been researched along with morphine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourin, M; Kõks, S; Soosaar, A; Vasar, E; Võikar, V1

Other Studies

1 other study(ies) available for butyloxycarbonyl-tryptophyl-methionyl-aspartyl-phenylalaninamide and morphine

ArticleYear
BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Neuropeptides, 1999, Volume: 33, Issue:1

    Topics: Analgesics, Opioid; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepinones; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fear; Injections, Subcutaneous; Locomotion; Male; Maze Learning; Morphine; Naloxone; Narcotic Antagonists; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tetragastrin

1999